Preclinical toxicology studies with azithromycin: genetic toxicology evaluation

https://doi.org/10.1016/0165-1218(93)90125-WGet rights and content

Abstract

Azithromycin was subjected to a series of three in vitro and one in vivo genetic toxicology assays for the detection of drug-associated gene or chromosomal effects. In the Ames Salmonella typhimurium tester strains TA1535, TA1537, TA98 and TA100, the presence of azithromycin was not associated with any increase in the number of his- revertants. Urine from mice dosed with up to 200 mg/kg of azithromycin also had no effect on the number of revertants in these same strains suggesting the absence of mutagenic excretory products following oral exposure. When tested up to the cytotoxic level of 240 μg/ml, of azithromycin caused to increase in the mutant frequency at the thymidine kinase locus of L5178Y/TK cells. Both the mammalian and microbiol gene mutation assays mutagenic included the presence of rat-liver postmitochondrial (S9) fraction for the detection of mutagenic biotransformation products. Mitogen-stimulated human lymphocytes cultured in the presence of 2.5–7.5 μg/ml azithromycin for 24 h or 30.0–40.0 μg/ml azithromycin for 3 h in the presence of rat S9 had chromosomal aberration frequencies that were no different than negative control cells even though slight to moderate mitotic suppression was associated with these concentrations. In vivo assessment of this compound was completed in male and female mice with a single oral dose of 200 mg/kg followed by sacrifice at 6, 24 or 48 h later and metaphase analysis of bone marrow for chromosomal aberrations. No statistically significant elevations of chromosomally aberrant cells were found. We conclude that azithromycin does not cause gene mutations in microbial or mammalian cells, or chromosomal aberrations in cultured human lymphocytes or in mouse bone marrow in vivo.

References (13)

There are more references available in the full text version of this article.

Cited by (14)

  • Effect of natamycin on cytochrome P450 enzymes in rats

    2013, Food and Chemical Toxicology
    Citation Excerpt :

    There are many contradictory results on the genotoxicity of macrolides. Some reports suggest that macrolides cause a genotoxic effect when using various test systems (Mitchell et al., 1980; Ila and Topaktas, 1999) but others show that some of the macrolides did not induce gene mutation (Sono et al., 1989; Amacher et al., 1993). Natamycin was found to be a non-mutagenic in Salmonella/mammalian microsome mutation assay in S. typhimurium strains, in a mouse lymphoma mutation assay, in chromosome aberration assay with Chinese hamster ovary (CHO) cells and it is not effective on the reproductive performance in rats (EMEA, 1998).

  • Micronucleus frequency in women with genital Chlamydia Trachomatis infection before and after therapy

    2006, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
  • Bacterial, Fungal, and Parasitic Disease

    2004, Medical Complications During Pregnancy
  • Azithromycin: the first of the tissue-selective azalides

    1995, International Journal of Antimicrobial Agents
View all citing articles on Scopus

Present address: Toxicology and Safety Assessment, Boehringer Ingelheim Pharmaceuticals, 90 East Ridge, P.O. Box 368, Ridgefield, CT 06877, USA.

View full text